The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

Early results from a phase 2 clinical trial show that denifanstat for 12 weeks improved lesion counts in patients with acne vulgaris.

Concerns about the state of the US health care system, including that it may be in crisis, were among the highest recorded levels.

The CDC no longer recommends universal hepatitis B vaccination at birth, instead excluding babies born to mothers negative for hepatitis B.

The FDA warned major retailers of possible legal action after they sold recalled infant formula amid an infant botulism outbreak.

Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.

Pediatric COVID vaccination reduced the risk of emergency room visits, especially in children aged 4 years and younger.

Tanning bed use was associated with higher risk for melanoma, melanoma on sites with low cumulative sun exposure, and multiple melanomas.

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

We spoke with multiple experts to discuss the challenges and developments in diagnosing Ehlers-Danlos Syndrome.

Patients with alopecia areata are at a greater risk for psychiatric disorders than control patients, including depression and anxiety, among others.

Most US adults, whether they are publicly or privately insured, report being satisfied with their health insurance.